Cancer

The Royal Children’s Hospital is now the home of Queensland’s only tertiary centre for the treatment of kids with cancer, the Queensland Children’s Cancer Centre, or QCCC.

Every year, 120-160 children are diagnosed with cancer, which is the most common cause of death in childhood, excluding accidents.

The Royal Children’s Hospital Foundation is investing in oncology research to help develop better and less invasive treatments for kids with cancer, and is proud to fund the work of Dr Andrew Hallahan, Director of the Children’s Cancer Research Laboratory at the Royal Children’s Hospital.

How does the RCH Help?

The Royal Children’s Hospital Foundation is investing in oncology research to help develop better and less invasive treatments for kids with cancer, and is proud to fund the work of Dr Andrew Hallahan, Director of the Children’s Cancer Research Laboratory at the Royal Children’s Hospital.

Our Research Breakthroughs

Oncology researchers at the Royal Children’s Hospital are working in partnership with researchers across the nation to better understand the biology of cancer in the hope of developing better therapies that not only do less damage to children, but also rid the cancer from their tiny systems.

Every year the Children’s Cancer Research Laboratory adds to the national and global knowledge pool about childhood cancer. This year they’ve worked in partnership with other researchers in Brisbane and America on a high-profile study to determine the effectiveness of blocking specific cell signal pathways critical for the growth and survival of brain tumours.

One of the vehicles contributing to this national research effort is the Queensland Children’s Tumour Bank, established with funding from the Royal Children’s Hospital Foundation.This year the Bank contributed tumour specimens to important leukaemia and sarcoma studies occurring around the nation.

On another front, researchers have an exciting new approach to study relapsed brain tumour cells resulting in new insights into this currently untreatable problem. With 40 to 50 percent of brain tumours returning in children, the findings have the potential to make a real difference to the lives of these little patients, who at this point in time, have no treatment options.

Our hope in 2009-10 and beyond is to:

• build on the opportunities our research into relapsed brain tumours has already uncovered to improve the effectiveness of radiation treatment
• collaborate with researchers at the Queensland Institute of Medical Research and the Institute for Molecular Bioscience to better characterise the critical tumour propagating cells that are responsible for treatment resistance and disease relapse
• continue to foster studies of cancer biology across Australia and the world through the Tumour Bank.

Read more about our cancer research in our fact sheet.